Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sylvia Nyilas (Basel, Switzerland), Sylvia Nyilas, Anja Bigler, Sophie Yammine, Cordula Koerner-Rettberg, Isabelle Rochat, Alexander Moeller, Gaudenz Hafen, Carmen Casaulta, Philipp Latzin, Florian Singer. Calculation of Scond between 0 and 3 lung turn over (Scond*) in mild to moderate chronic lung disease. Eur Respir J 2016; 48: Suppl. 60, 1230

Member's Comments

No comment yet.

Related content which might interest you: Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI) Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016 Measuring lung inhomogeneity in early chronic lung disease Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context Year: 2013 Lung function in school age children with chronic lung disease of prematurity Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015 Ventilation inhomogeneity in children with severe asthma and normal spirometry indicates residual airways disease Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children Year: 2013 Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement Year: 2015 Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Emphysematous lung sealant (ELS) therapy reduces CRP, an index of inflammation, in patients with severe emphysema (clinicaltrials.gov #NCT NCT00884962) Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015